Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read ...
Built by two experienced advisers, these portfolios target strong, consistent returns with minimal connection to share market ...
Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.
BofA Securities maintains Buy on Chevron with $183 target, citing strong free cash flow, Hess synergies, structural cost ...
Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...
By bne IntelliNews US-based supermajor Chevron unveiled its plans for the next five years at its investor day on November 12.
Highlights Expects adjusted free cash flow annual growth greater than 10% at $70 Brent Reduces capex guidance range to $18 to $21 billion per year Forecasts earnings per shar. . .